Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting entities : Scopus biopharma inc save search
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2023-11-07 (Crawled : 14:00) - globenewswire.com
SCPS | $0.1682
|
| Email alert
Add to watchlist
cancer treatment immunotherapy meeting
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
SCPS | $0.1682
|
| Email alert
Add to watchlist
cancer immunotherapy meeting
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
SCPS | $0.1682
|
|
| O: 3.29%
H: 12.99%
C: 10.73%
immunotherapy meeting cancer
Dr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual Meeting
Published: 2021-12-06 (Crawled : 13:00) - biospace.com/
SCPS | $0.1682
|
|
| O: -4.67%
H: 0.0%
C: 0.0%
biopharma
Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders
Published: 2021-10-08 (Crawled : 22:00) - globenewswire.com
SCPS | $0.1682
|
| Email alert
Add to watchlist
biopharma
Scopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Published: 2021-09-29 (Crawled : 13:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -0.5%
H: 10.3%
C: 0.75%
biopharma leo preclinical pre-clinical
Scopus BioPharma to Adjourn 2021 Annual Meeting of Stockholders
Published: 2021-09-28 (Crawled : 11:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -0.25%
H: 3.75%
C: 0.0%
biopharma
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Published: 2021-09-28 (Crawled : 11:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -0.25%
H: 3.75%
C: 0.0%
biopharma leo
Scopus BioPharma's Subsidiary — Duet Therapeutics — to Present at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Published: 2021-09-22 (Crawled : 13:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: 1.7%
H: 5.74%
C: 1.91%
biopharma leo
Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting
Published: 2021-09-20 (Crawled : 13:15) - prnewswire.com
SCPS | $0.1682
|
|
| O: -5.26%
H: 2.47%
C: -12.35%
XTLB | $2.56 -1.16% -4.02% 33K
|
Health Technology
|
| O: -3.79%
H: 7.39%
C: 1.72%
biopharma
Scopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium Meeting
Published: 2021-09-03 (Crawled : 14:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -6.61%
H: 2.12%
C: 0.35%
biopharma
Scopus BioPharma Announces New Date for 2021 Annual Meeting of Stockholders
Published: 2021-06-01 (Crawled : 01:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: 0.85%
H: 6.44%
C: -1.26%
biopharma
Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders
Published: 2021-05-26 (Crawled : 00:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -2.71%
H: 12.52%
C: 0.25%
biopharma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.